Resistant hypertension (RHT) is defined as an uncontrolled office blood pressure (BP) despite the use of an optimal regimen with at least 3 antihypertensive drugs or use of ≥4 antihypertensive drugs, ideally including a diuretic, regardless of office BP levels. 1 Although RHT definition is based on office BP measurements and number of antihypertensive drugs in use, ambulatory BP monitoring (ABPM) is a well-established indication in RHT management, 1-3 not only for determining the baseline diagnosis 4-6 and prognosis 7,8 but also for follow-up and treatment. 9-12 ABPM classifies resistant hypertensive patients into 4 subgroups according to uncontrolled ambulatory BP (true RHT or masked RHT) and controlled ambulatory BP (white-coat RHT or controlled RHT), and this classification determines the therapeutic approach and contributes to prognostic evaluation. 2,6,11 During followup, patients with uncontrolled ambulatory BPs will need to repeat ABPM at each drug adjustment, 11 whereas those with controlled ambulatory BP should repeat the procedure at least annually. 12 Home BP monitoring (HBPM) is another method of obtaining out-of-office BP measurements, and it is becoming increasingly used in the diagnosis and management of arterial hypertension. Even though HBPM and ABPM were initially considered alternative techniques and not complementary ones, nowadays there are many studies supporting the recommendation for more extensive use of HBPM in clinical practice, especially because of some limitations of ABPM, such as higher cost of the devices, the need for a trained clinic staff, lower patient acceptance, and less availability in routine clinical practice, at least for serial performances. 13 Consequently, its use has also been spread to resistant hypertensive patients. Nevertheless, it is not clear whether this procedure can be actually applied to this group of patients for diagnosis, 14 follow-up, 15 and prognostic evaluation, 13 as is currently recommended for ABPM. Therefore, the objective of our study was to evaluate HBPM usefulness in the management of patients with RHT, in comparison with the gold-standard ABPM. background Ambulatory blood pressure (BP) monitoring (ABPM) is a cornerstone in resistant hypertension (RHT) management. However, it has higher cost and lower patients' acceptance than home BP monitoring (HBPM). Our objective was to evaluate HBPM usefulness in the management of patients with RHT.
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Resistant hypertension (RHT) is defined as an uncontrolled office blood pressure (BP) despite the use of an optimal regimen with at least 3 antihypertensive drugs or use of ≥4 antihypertensive drugs, ideally including a diuretic, regardless of office BP levels. 1 Although RHT definition is based on office BP measurements and number of antihypertensive drugs in use, ambulatory BP monitoring (ABPM) is a well-established indication in RHT management, [1] [2] [3] not only for determining the baseline diagnosis [4] [5] [6] and prognosis 7, 8 but also for follow-up and treatment. [9] [10] [11] [12] ABPM classifies resistant hypertensive patients into 4 subgroups according to uncontrolled ambulatory BP (true RHT or masked RHT) and controlled ambulatory BP (white-coat RHT or controlled RHT), and this classification determines the therapeutic approach and contributes to prognostic evaluation. 2, 6, 11 During followup, patients with uncontrolled ambulatory BPs will need to repeat ABPM at each drug adjustment, 11 whereas those with controlled ambulatory BP should repeat the procedure at least annually. 12 Home BP monitoring (HBPM) is another method of obtaining out-of-office BP measurements, and it is becoming increasingly used in the diagnosis and management of arterial hypertension. Even though HBPM and ABPM were initially considered alternative techniques and not complementary ones, nowadays there are many studies supporting the recommendation for more extensive use of HBPM in clinical practice, especially because of some limitations of ABPM, such as higher cost of the devices, the need for a trained clinic staff, lower patient acceptance, and less availability in routine clinical practice, at least for serial performances. 13 Consequently, its use has also been spread to resistant hypertensive patients. Nevertheless, it is not clear whether this procedure can be actually applied to this group of patients for diagnosis, 14 follow-up, 15 and prognostic evaluation, 13 as is currently recommended for ABPM. Therefore, the objective of our study was to evaluate HBPM usefulness in the management of patients with RHT, in comparison with the gold-standard ABPM. This is a cross-sectional study that enrolled 240 patients from a cohort of resistant hypertensive patients attending a university hospital hypertension clinic between September 2010 and May 2013. The study protocol was previously approved by the local ethics committee, and all participants gave written informed consent. A database was developed for use at the entry of each patient into the cohort 4,7 that included demographic and anthropometric characteristics (sex, age, race, weight, height, and waist circumference), cardiovascular risk factors (diabetes, dyslipidemia, smoking, physical inactivity, and obesity), and target-organ damage (coronary heart disease, heart failure, cerebrovascular disease, advanced retinopathy, and peripheral arterial disease). 3 In a clinical interview, the attending physician recorded the antihypertensive scheme in use and checked therapeutic adherence using a standard questionnaire. 16 The exclusion criteria were low adherence, cognitive impairment, and any concomitant severe systemic disease.
BP measurements
All BP measurements were performed within 4 weeks, and antihypertensive drug treatment was stable for at least 1 month before BP measurements. Office BP was measured twice in the sitting position by the attending physician using a digital oscillometric BP monitor (HEM-907 XL; Omron Healthcare, Kyoto, Japan) 17 with suitably sized cuff, and the BP considered was the mean of the 2 readings. 3 ABPM was recorded within 2 weeks using Mobil-O-Graph (version 12, DynaMAPA; Cardios, São Paulo, Brazil) equipment, which is approved by the British Society of Hypertension. 18 Readings were taken every 15 minutes throughout the day and every 30 minutes at night. The procedure was considered satisfactory if at least two-thirds of anticipated BP measurements during the daytime and nighttime periods were recorded. Exams with no valid readings for ≥2 hours were excluded from the analysis. 19 Parameters evaluated were mean 24-hour, daytime, and nighttime systolic BP (SBP) and diastolic BP (DBP), and the magnitude of the white-coat effect (WCE), estimated as the difference between office and ambulatory daytime measurements. The nighttime period was ascertained for each individual patient from registered diaries.
HBPM protocol was designed according to current recommendations 13 and was initiated at the day after ABPM.
On this morning, clinic BP was measured by a nurse while the patient was in the sitting position using the same BP monitor (HEM-907 XL) and the same protocol used previously by the physician. HBPM was performed using a validated oscillometric BP device (HEM-705 CP; Omron Healthcare, Kyoto, Japan), 20 which has a memory capable of storing up to 30 readings, with a suitably sized cuff. Patients were instructed to take triplicate morning (6:00-10:00 am) and evening (6:00-10:00 pm) measurements just before their morning and evening medication doses during 5 routine days while relaxed in the sitting position with back and arm supported and legs uncrossed. The measurement was always done on the same arm (in case of significant between-arm difference, the arm with the higher BP was selected) with at least a 2-minute interval between measurements. 13 The first day BP measurements were discarded, as they are usually higher, seeming to reflect residual WCE. The parameters evaluated were mean SBP and DBP (mean BP of 4 days), mean first day SBP and DBP, mean morning and evening SBP and DBP, and the magnitude of WCE, estimated as the difference between office and mean home BP measurements. The procedure was considered successful if it achieved a minimum of 12 measurements. 13 All home BP readings, with their respective date and hour, were downloaded from the devices by our nursing staff just after the devices were returned by the patients; any BP recordings outside the scheduled days and hours of measurement were discarded. The mean number of home BP measurements was 21 per patient. All patients used their prescribed antihypertensive medications during ABPM and HBPM. A single independent observer unaware of other patients' data analyzed the results of ABPM and HBPM.
Different categories of RHT patients, defined according to office, home, and ambulatory BP levels, 13, 14 are outlined in Table 1 . We primarily used ambulatory daytime BPs to define categories according to ABPM because HBPM does not measure nighttime (sleep) BPs; hence, it cannot detect isolated nocturnal hypertension. However, in an alternative analysis, we used both daytime and nighttime BPs to define categories of RHT by ABPM.
Statistical analysis
The statistical analyses were performed with SPSS 19.0 (SPSS, Chicago, IL). Continuous variables were described as means (SDs) when normally distributed or as medians (range) when asymmetrically distributed. Bivariable comparisons between patients with controlled and uncontrolled out-of-office BPs were performed by unpaired t test 21 to evaluate agreement between HBPM and daytime ABPM measurements and calculated the repeatability coefficients (twice the SDs of the differences between the 2 measurements). Higher repeatability coefficient means lower within-subject agreement. The repeatability coefficients were also expressed as a percentage of nearly maximal variation-that is, the interval encompassing 4 times the SD of the averaged duplicate measurements; 21, 22 the lower the value, the better the agreement between HBPM and ABPM measurements.
RESULTS
A total of 240 patients (74.0% women; mean age = 66.9 years; SD = 10.6 years) were enrolled into the study. Patients with uncontrolled ambulatory BP had a higher prevalence of diabetes and heart failure, whereas those with uncontrolled home BP had less dyslipidemia. Patients with uncontrolled out-of-office BP measurements were using more antihypertensive drugs (Table 2 ) and had higher office SBP. The therapeutic scheme was similar in the 2 groups, except that patients with uncontrolled ABPM and HBPM were using more potassium-sparing diuretics and loop diuretics. As expected, all systolic and diastolic ambulatory and home BPs were higher in patients with uncontrolled ambulatory BP (Table 3) .
On ABPM 139 patients (58%) presented controlled ambulatory BP, whereas on HBPM only 85 patients (35%) presented controlled home BP (Figure 1 ). The performance of HBPM in detecting different categories of RHT diagnosed by ABPM is outlined in Table 4 . A high specificity was found for patients with controlled HBPM (controlled RHT and white-coat RHT) with high positive predictive value and Table 2 . Baseline characteristics of all patients and grouped according to controlled or uncontrolled out-of-office blood pressure measurements Abbreviations: ACE, angiotensin-converting enzyme; AR, angiotensin II receptor; BP, blood pressure; MR, mineraloreceptor. *P < 0.001, **P < 0.01, ***P < 0.05 refer to bivariable comparisons between patients with controlled and uncontrolled ambulatory blood pressures and between patients with controlled and uncontrolled home blood pressures.
positive likelihood ratio, meaning that patients with controlled HBPM have a high possibility (5.5-fold for white-coat RHT and 9-fold for controlled RHT) to have this diagnosis confirmed by ABPM. Hence, a normal result on HBPM (<135/85 mm Hg) does not need to be confirmed by ABPM, whereas a high BP on HBPM will still need ABPM confirmation. The best accuracy was found in patients with uncontrolled office BP (true and white-coat RHT) with moderate agreement (kappa = 0.449). A total of 57 patients (24%) presented isolated uncontrolled nocturnal RHT that obviously was not identified by HBPM. Using both ambulatory daytime and nighttime BPs to classifying RHT patients decreased the specificity and positive predictive value of HBPM for detecting controlled ambulatory BP levels (Table 4) .
Patients had higher SBP on HBPM than during the daytime period of ABPM (143 vs. 134 mm Hg) and, consequently, had lower extent of the systolic WCE in comparison with the ABPM (14 vs. 23 mm Hg) ( Table 3) . In other words, there was still a residual 9-mm Hg WCE (95% confidence interval = 7-11 mm Hg) in HBPM. Figure 2 shows BlandAltman graphics for agreement between systolic and diastolic daytime ambulatory and home BPs. Home/ambulatory daytime had a mean difference of 8.8 mm Hg in SBP (95% of the differences were between −21.6 and +39.2 mm Hg) and a mean difference of 0.2 mm Hg in DBP (95% of the differences between -19.4 and +19.8 mm Hg).
The simple correlation coefficients were significantly high both for SBP and DBP and for the WCE, but this coefficient does not accurately assess agreement. 21, 22 After assessing agreement between the ABPM and HBPM by Bland-Altman repeatability coefficients, a high within-subject agreement was found for DBP and diastolic WCE, and moderate agreement was found for systolic measurements. As percentage of nearly maximal variation, there was also a (27) 15 (26) 11 (28) DBP white-coat effect 7 (14) 9 (13) 6 (15) Values are presented as means (SD) unless otherwise noted. Office blood pressure was measured by the physician. Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure. *P < 0.001 for bivariable comparisons between groups with controlled and uncontrolled ambulatory blood pressure monitoring.
high agreement for DBP measurements and moderate for SBP (Table 5) .
DISCUSSIOn
The main finding of our study is that in a large cohort of resistant hypertensive patients, HBPM showed a good performance in detecting different categories of RHT diagnosed by ABPM, particularly in patients with controlled ambulatory BPs (white-coat and controlled RHT). Although HBPM still overestimated SBP (by a mean of 9 mm Hg), it demonstrated a good agreement with ABPM and can be used as a complementary method in the follow-up of patients with RHT.
In 1988, Pickering recommended that patients with RHT without signs of target-organ damage should be submitted to HBPM. If home BP values were low, ABPM was indicated to confirm the findings and patients should be treated and followed-up by HBPM. 23 Nowadays, RHT is a well-established indication for out-of-office BP measurements. 3, 13, 19 Nevertheless, there are many studies evaluating ABPM in RHT for diagnosis, 2,4-6 follow-up, [9] [10] [11] [12] and prognosis, 7, 8, 11 but few studies focusing on HBPM in RHT. 14, 15, 24, 25 The J-HOME study was the first to describe the characteristics of 528 resistant hypertensive patients determined by HBPM. 14 Patients were classified as true RHT (43%), whitecoat RHT (16%), masked RHT (23%), and controlled RHT (18%). Masked RHT was associated with coronary heart disease, and white-coat RHT was associated with a high prevalence of dyslipidemia. In our series, we found similar prevalences, with 35% of patients with controlled home BP (Figure 1 ), and patients with uncontrolled home BP had higher office SBP but used more antihypertensive drugs (especially mineraloreceptor blocker diuretics). As in J-HOME, patients with controlled HBPM presented more dyslipidemia (Table 1) .
A recent meta-analysis 26 that evaluated the effectiveness of HBPM compared with ABPM for diagnosis of hypertension found a high sensitivity (85.7%) and moderate specificity (62.4%), similar to our results. Three studies [27] [28] [29] evaluated the diagnostic performance of HBPM in detecting white-coat hypertension in untreated patients with controversial findings. Two of them, 27,28 which evaluated 181 and 156 patients, respectively, found a low sensitivity (50% and 62%) and moderate specificity (76% and 65%), concluding that HBPM had a poor accuracy to detect white-coat hypertension. The third one 29 evaluated 247 patients and found a larger WCE in HBPM than in ABPM with lower home SBP (5.0 mm Hg; kappa = 0.74) and DBP (3.5 mm Hg; kappa = 0.60). With a high specificity (89%) and moderate sensitivity (68%), the authors recommended HBPM as a good screening for white-coat hypertension. Another study, 30 which included 133 untreated patients, investigated whether HBPM and ABPM could be considered alternative methods to the conventional diagnosis of hypertension by repeated office BP measurements. Moderate sensitivity and specificity of HBPM compared with ABPM were found in detecting hypertension (74% and 76%), white-coat hypertension (61% and 79%), and WCE (62% and 86%), concluding that HBPM could be useful as a screening test but requires ABPM confirmation.
The largest study enrolled 613 treated (41%) and untreated (59%) hypertensive patients and evaluated the accuracy of HBPM in diagnosing sustained hypertension, WCE, and masked hypertension. 31 The agreement was high (89%) for all diagnoses, and only 27 patients (4%) showed BP differences >5 mm Hg. The sensitivity and specificity for detecting sustained hypertension were 90% and 89%, respectively, for detecting sustained hypertension; 61% and 94%, respectively, for detecting WCE; and 60% and 93%, respectively, for detecting masked hypertension. The authors concluded that HBPM was a good alternative to diagnose hypertension and to detect the white-coat and masked hypertension effects. These results were supported by a recent systematic review. 32 Moreover, a recent randomized trial suggested that general hypertensive patients can be managed either by ABPM or HBPM with similar results regarding BP control and target-organ damage development. 33 In patients with RHT, a specific group of hypertensive patients with well-known exaggerated WCE, 4 there are only 3 studies evaluating the usefulness of HBPM. 15, 24, 25 One study compared office, home, and ambulatory BPs in 51 resistant hypertensive patients. 24 HBPM overestimated SBP by 6.7 mm Hg and underestimated DBP by 2.7 mm Hg with a good correlation evaluated by kappa coefficient (kappa = 0.70 and 0.69, respectively). Only 4 patients (8.0%) were misdiagnosed as true RHT, and the authors concluded that HBPM may be a useful tool in the diagnosis of these patients. The other study evaluated 73 subjects using >3 antihypertensive drugs. 15 ABPM and HBPM diagnosed true RHT in 39% and 44% of patients, respectively; masked RHT in 16% and 26% of patients, respectively; whitecoat RHT in 22% and 16% of patients, respectively; and controlled RHT in 23% and 14% of patients, respectively; with an overall agreement of 82%. Agreement was also evaluated only by kappa coefficient (kappa = 0.59). The sensitivity, specificity, Numbers are for the white-coat resistant hypertension (RHT) diagnosis (in relation to true RHT diagnosis) and for the controlled RHT diagnosis (in relation to masked RHT diagnosis).
Abbreviations: BP, blood pressure; LR(+), positive likelihood ratio; LR(−), negative likelihood ratio; NPV, negative predictive value; PPV, positive predictive value. and positive and negative predictive values of HBPM in detecting true RHT were 90%, 55%, 71%, and 82%, respectively, showing that HBPM may be a reliable alternative to ABPM in the evaluation of resistant hypertensive patients. Neither study evaluated the prevalence of isolated uncontrolled nocturnal RHT nor assessed agreement by other methods than simple kappa coefficients. The most recent study evaluated the prevalences of true (10%) and white-coat RHT (28%) by HBPM among 302 treated hypertensive patients, but did not compare these results with ABPM. 25 Therefore, it is possible that the main disparity on SBP between HBPM and ABPM is related to the characteristically large WCE of RHT patients, in whom HBPM performance may still provoke a residual smaller WCE. However, a methodological issue regarding BP measurements, such as the order effect bias, cannot be completely ruled out.
One of the most important limitations of HBPM is the lack of nighttime recordings. 13 Nondipping pattern is extremely common in resistant hypertensive patients, 1, [4] [5] [6] and it was shown that both nocturnal BPs 7 and dipping pattern 8 are important prognostic markers in RHT. Moreover, the improvement of BP control achieved with chronotherapy is important in RHT, and it is based on ABPM. [9] [10] [11] Indeed, as can be observed from Table 4 , considering both daytime and nighttime BPs to classify patients with ABPM decreases the specificity and the positive predictive values of HBPM to detect controlled ambulatory BP categories (controlled and white-coat RHT). Therefore, the isolated use of HBPM in this group of patients is not indicated because the nocturnal profile needs to be evaluated. In our series, 24% of patients were diagnosed with isolated nocturnal RHT, and the prevalence of a nondipping pattern was 67%. This fact reinforces that HBPM may be a complementary method but not a substitute for ABPM assessment in RHT management. 13 Poor adherence is considered the major cause of lack of BP control, and it is recognized as an important cause of pseudoresistance. 1 Moreover, HBPM is considered an educational tool because it enhances the understanding of hypertension, improving the patients' compliance. 13 Hence, it may be another reason to consider HBPM as a good method for the long-term follow-up of resistant hypertensive patients, although more studies are necessary to confirm this. In the general population and the hypertensive population, home BP measurements are considered a good predictor of cardiovascular morbidity and mortality, 13, 34, 35 but there is no prospective study evaluating the prognostic value of HBPM in resistant hypertensive patients. An international database of HBPM to evaluate cardiovascular outcome (IDHOCO) is being built, and it will reinforce the prognostic importance of HBPM. 36 Our study has some limitations. The principal limitation is that all subjects were already in a long follow-up in our cohort. In this way, more than half of them (58%) had already achieved good ambulatory BP control under intensive treatment of up to 9 antihypertensive drugs. If HBPM was done at entrance to the cohort, we may have found different results because we showed that better accuracy is observed in patients with controlled office BP (30%) and we also showed a high specificity for patients with controlled ambulatory BP. An order effect bias also may have influenced our results because all patients first performed ABPM followed by HBPM. Although order effects are usually more important in questionnaires, where the order of the questions has marked influences on the answers, it can also affect intervention results, where the effect is rather unpredictable and cannot be accounted for. However, if an order effect was partially responsible for the 9-mm Hg difference in SBP between HBPM and ABPM, it would be expected also to affect DBP, which was not observed. A randomized order of performing ABPM and HBPM would surely be more scientifically rigorous. Lastly, this study enrolled only patients with RHT, and these results may not be generalized to other lesssevere hypertensive individuals. The main strengths of the study are the large number of resistant hypertensive patients evaluated and the statistical analysis because we assessed the agreement between HBPM and ABPM by Bland-Altman methods, beyond kappa and correlation coefficients.
In conclusion, HBPM may be useful in the follow-up of resistant hypertensive patients, but it does not substitute for ABPM. Ideally, all resistant hypertensive patients should be submitted to ABPM at the moment of the diagnosis to determine the actual magnitude of the WCE and to evaluate the nocturnal profile. 2, 3, [6] [7] [8] Provided that isolated nocturnal hypertension is discarded, HBPM can be used in the followup of resistant hypertensive patients, particularly in those with controlled ambulatory BPs, instead of repeating ABPM, Blood pressure values are means (SDs). Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; WCE, white-coat effect (difference between office and daytime BPs).
*P < 0.001.
to ascertain permanence of BP control. Otherwise, resistant hypertensive patients with high home BPs should still confirm uncontrolled BP levels with ABPM. Future prospective investigations are necessary to evaluate the usefulness of HBPM in the therapeutic approach of RHT to achieve optimal BP control, as well as to identify the prognostic value of HBPM parameters. Moreover, it should be addressed whether HBPM is capable of enhancing treatment adherence in patients with RHT.
